Market News

Alkermes plc (NASDAQ:ALKS) today announced results from a planned interim analysis of the ongoing long-term extension (LTE) study evaluating alixorext...

JP Morgan analyst Jessica Fye reinstates BioCryst Pharma (NASDAQ:BCRX) with a Neutral and announces $12 price target.

Keybanc analyst Jeffrey D. Hammond initiates coverage on SiteOne Landscape Supply (NYSE:SITE) with a Overweight rating and announces Price Target o...

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $72 to $108.

First Hawaiian, Inc. (NASDAQ:FHB) ("First Hawaiian"), parent company of First Hawaiian Bank, and TriCo Bancshares (NASDAQ:TCBK) ("TriCo&#3...

CNBC's Andrew Ross Sorkin reports on the latest news.

Apple sues OpenAI, former employees. This strike could cost Hyundai. Wall Street is craving CAKE.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that the first participant has been dosed in the Phase 1-2 ASCEND study of ION337, an invest...

JP Morgan analyst Jessica Fye reinstates Denali Therapeutics (NASDAQ:DNLI) with a Overweight and announces $29 price target.

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the ...

JP Morgan analyst Jessica Fye reinstates Legend Biotech (NASDAQ:LEGN) with a Neutral and announces $35 price target.

Application based on results from SUCCESSOR-2 trial showing oral CELMoD mezigdomide in combination with carfilzomib and dexamethasone significantly im...

Mizuho analyst Ann Hynes maintains Charles River (NYSE:CRL) with a Neutral and raises the price target from $192 to $230.

Cisco and Planet Fitness have been highlighted as Zacks Bull and Bear of the Day

Elon Musk’s space-and-AI company lost $4.9 billion last year and trades at 97 times sales. Investors need a lot to go right.

JP Morgan analyst Jessica Fye reinstates Alkermes (NASDAQ:ALKS) with a Neutral and announces $60 price target.

Boeing [NYSE: BA] will showcase its leading commercial, defense and services portfolio at the Farnborough International Airshow, reaffirming its commi...

After a rocky start to the year, health insurer stocks have roared back. The insurers are trying to end a difficult cycle that began about three year...

JP Morgan analyst Richard Shane upgrades American Express (NYSE:AXP) from Neutral to Overweight and raises the price target from $328 to $400.

Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $215 to $230.